Literature DB >> 7697967

Association of cerebral vasculitis with a lupus anticoagulant. A case with brain pathology.

E Toussirot1, D Figarella-Branger, P Disdier, J R Harle, P J Weiller.   

Abstract

The authors report the case of a sixty-five year old woman initially suffering from a thrombocytopenia. The patient was diagnosed as having an autoimmune disease with a lupus anticoagulant, positive antinuclear antibodies and negative anti-DNA antibodies. She then developed an encephalopathy which was fatal despite corticosteroids. Brain pathology revealed a vasculitis with some giant cells, evoking a granulomatous angiitis of the central nervous system. These clinical and biological features suggest a systemic lupus erythematosus with vasculitis or a primary granulomatous angiitis of the central nervous system. Taking into account the clinical manifestations and the presence of a lupus anticoagulant, we finally preferred to identify it as a primary antiphospholipid antibodies syndrome, despite absence of anticardiolipin antibodies. Contrary to thrombosis, vasculitis is rarely associated with an anticardiolipin antibody or a lupus anticoagulant. However, vasculitis in the course of primary antiphospholipid antibodies syndrome has been reported previously as in this case report.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7697967     DOI: 10.1007/bf02243006

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  15 in total

Review 1.  Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance.

Authors:  P E Love; S A Santoro
Journal:  Ann Intern Med       Date:  1990-05-01       Impact factor: 25.391

2.  The neurological manifestations of systemic lupus erythematosus.

Authors:  R T Johnson; E P Richardson
Journal:  Medicine (Baltimore)       Date:  1968-07       Impact factor: 1.889

3.  Nervous system involvement in systemic lupus erythematosus.

Authors:  T Gibson; A R Myers
Journal:  Ann Rheum Dis       Date:  1975-10       Impact factor: 19.103

4.  Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases.

Authors:  S R Levine; M J Deegan; N Futrell; K M Welch
Journal:  Neurology       Date:  1990-08       Impact factor: 9.910

Review 5.  Antiphospholipid antibody syndrome: immunologic and clinical aspects.

Authors:  L R Sammaritano; A E Gharavi; M D Lockshin
Journal:  Semin Arthritis Rheum       Date:  1990-10       Impact factor: 5.532

Review 6.  Angiitis of the central nervous system.

Authors:  J T Lie
Journal:  Curr Opin Rheumatol       Date:  1991-02       Impact factor: 5.006

7.  Brain pathology in systemic lupus erythematosus.

Authors:  J G Hanly; N M Walsh; V Sangalang
Journal:  J Rheumatol       Date:  1992-05       Impact factor: 4.666

8.  Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus.

Authors:  D Alarcón-Segovia; M E Pérez-Vázquez; A R Villa; C Drenkard; J Cabiedes
Journal:  Semin Arthritis Rheum       Date:  1992-04       Impact factor: 5.532

Review 9.  Primary angiitis of the central nervous system. Report of 8 new cases, review of the literature, and proposal for diagnostic criteria.

Authors:  L H Calabrese; J A Mallek
Journal:  Medicine (Baltimore)       Date:  1988-01       Impact factor: 1.889

10.  Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome.

Authors:  R A Asherson; M A Khamashta; A Gil; J J Vazquez; O Chan; E Baguley; G R Hughes
Journal:  Am J Med       Date:  1989-04       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.